Senior insider sale
Chief Accounting Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$175.8K
1.54K shares
What this filing means
LYON JOSEPH DOUGLAS plans to sell 1.54K shares of CORCEPT THERAPEUTICS INC valued at approximately $175.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/3/2026ACC: 0001973251-26-000029
Officer· Chief Accounting Officer
Since Jul 2020
1.54K
Shares to sell
$175.8K
Approx. market value
1.54K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Option Exercise
Cash
6/3/2025
791.00Option Exercise
Cash
6/2/2025
749.00Total acquired1.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2025 | Option Exercise Cash | 791.00 | — |
6/2/2025 | Option Exercise Cash | 749.00 | — |
| Total | 1.54K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.54K
Market value
$175.8K
8/3/2026
Total
Units
1.54K
Value
$175.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/3/2026 | 1.54K | $175.8K | NASDAQ | Planned |
| Total | 1.54K | $175.8K | ||